From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: And today's big new shorting idea is...Celadon Pharmaceuticals

By Tom Winnifrith | Thursday 23 March 2023

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

I start with a grumpy old man rant about standards in public and corporate life covering a lying Boris, Wildcat (WCAT) and Osirium (OSI) before moving onto the missing £20 million and the fraud Supply@ME Capital (SYME). I cover Amigo (AMGO), Versarien (VRS) and the liquidity trap, Inland (INL), Advanced Oncotherapy (AVO) before I turn my fire on Celadon (CEL). Finally I urge you to donate to Rogue Bloggers for Woodlarks as I outline my third training walk on Saturday. C'mon you can afford a tenner HERE
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



Van Elle Holdings – a Buy?

Thursday »


Character Group – a Buy?



Ingenta – now a Buy again?



Which PR genius wrote this?



H&T Group – now again a Buy

Time left: 11:46:24